PMC2636066_01
BCC below the inferior lacrimal canaliculus
IndianJOphthalmol-56-85-g001.jpg
PMC2636066_01_IndianJOphthalmol-56-85-g001.jpg
F1
We used INF alpha 2b for management of a BCC below the right inferior canaliculus in a 77-year-old man [Fig. 1].
BCC six months after treatment with intralesional interferon alpha 2b. The tumor persists. A nodular lesion is also present
IndianJOphthalmol-56-85-g002.jpg
PMC2636066_01_IndianJOphthalmol-56-85-g002.jpg
F2
The lesion persisted during the follow-up of six months [Fig. 2].